News

AbbVie Inc (ABBV) surpasses expectations with robust sales growth in Skyrizi and Rinvoq, while navigating challenges in ...
Some of the challenges holding the dentistry industry back from advancing further include rising costs, student loan debt and insurance reimbursements, according to those in the industry. Six dentists ...
Disgraced former Republican politician George Santos, who was expelled from the US Congress for using stolen donor cash to bankroll a lavish lifestyle including designer suits, Botox and subscriptions ...
AbbVie Inc. reports a strong Q1 2025 with EPS of $2.46 and raised guidance, fueled by Skyrizi, Rinvoq, and neuroscience growth.
Drugmaker AbbVie plans to invest more than $10 billion in domestic manufacturing and other capabilities over the next decade, including building four new plants. The North Chicago, Ill.-based ...
For 2025, AbbVie forecast adjusted earnings per share at between $12.09 to $12.29, compared with earlier guidance in the range of $11.99 to $12.19. It noted that the current guidance is based on the ...
Credit unions across the country saw member savings and loans, particularly mortgages, increase over the latest financial ...
Despite being on the US market since 1989 – initially for medical uses like strabismus and blepharospasm, and later for ...
Our beauty team has tried and tested a range of the best wrinkle-busting creams, serums and fillers on the market so you ...
The bride-to-be, who is a B2B growth marketer at UpKeep, came up with the idea during a root touch-up appointment. While ...